In the past five years, Pradaxa bleeding litigation has spawned hundreds of product liability lawsuits and record-breaking settlements.
Now, the manufacturer of the new generation blood thinner, Boehringer Ingelheim Pharmaceuticals, may soon find redemption in the public’s eye, as its bleeding antidote may be approved by the end of this year.
Pradaxa Antidote Set For FDA Review
Early results from a new study indicates that an experimental drug may be able to reverse the Pradaxa bleeding effects, which may be released by the end of 2015.
In April 2015, the FDA stated that it would conduct a priority review of the application, in order to speed along the approval process for the potential Pradaxa bleeding antidote, Idarucizumab, once the current study is complete.
The ongoing study was recently published in the New England Journal of Medicine and is being conducted to determine whether or not Idarucizumab would be an effective reversal agent for Pradaxa bleeding injuries.
According to the Pradaxa antidote study, the mechanism behind Idarucizumab is the binding process that streamlines the drug’s blood-thinning abilities.
While the reversal effects of this potential Pradaxa antidote was not immediately active, normal blood clotting ability was restored in minutes while not promoting adverse blood-clotting formations.
Essentially, experts are excited for Idarucizumab because it could be a safe method of stopping internal bleeding for Pradaxa patients, as vitamin K does for Warfarin patients.
Overview of Pradaxa Bleeding Complications
When Pradaxa was approved in 2010, it was the first anticoagulant to breach the market since the release of Warfarin in 1936. Boehringer Ingelheim Pharmaceuticals reportedly spent over $400 million to promote the drug and was met with very profitable rewards. By August 2012, more than 3.7 million patients had been prescribed Pradaxa, successfully outpacing Warfarin in popularity.
Pradaxa’s success inspired American pharmaceutical companies to try their luck in the lucrative anticoagulant market, resulting in the release of Xarelto and Eliquis; these three drugs together have since been categorized as new generation blood thinners.
However in those two years of its arrival, Pradaxa has been blamed for nearly 600 deaths due to sudden uncontrollable internal bleeding events.
Each of these new anticoagulant drugs were advertised to be faster-acting and more efficient than Warfarin, along with being prescribed in a single dose. In contrast, Warfarin patients are required to frequently see their physicians for dose adjustments and are under constant blood monitoring.
However, medical experts believe that if these requirements were conveyed to Pradaxa and the other new generation anticoagulants users, then numerous bleeding events could have been prevented.
Pradaxa Lawsuits
If patients using Pradaxa experience an internal bleeding event and are not hospitalized in time, the bleeding injuries could become fatal.
This Pradaxa side effect has spurred thousands of patients, who were prescribed the anticoagulant to prevent stroke, to file Pradaxa bleeding lawsuits against Boehringer Ingelheim Pharmaceuticals.
The litigation movement came to a head in May 2014, when the drug maker settled more than 4,000 Pradaxa bleeding lawsuits for $650 million.
While Boehringer Ingelheim has made great strides in a potential antidote, for many patients who experienced a dangerous internal bleeding event, the Pradaxa antidote is too late.
In general, Pradaxa lawsuits are filed individually by each plaintiff and are not class actions.
Do YOU have a legal claim? Fill out the form on this page now for a free, immediate, and confidential case evaluation. The Pradaxa attorneys who work with Top Class Actions will contact you if you qualify to let you know if an individual lawsuit or Pradaxa class action lawsuit is best for you. Hurry — statutes of limitations may apply.
Top Class Actions is a Proud Member of the American Bar Association
LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
©2008 – 2015 Top Class Actions® LLC
Various Trademarks held by their respective owners
Get Help – It’s Free
Join a Free Pradaxa Class Action Lawsuit Investigation
If you, or a loved one, experienced Pradaxa side effects, you may have a legal claim. Submit your information now for a free case evaluation.
An attorney will contact you if you qualify to discuss the details of your potential case at no charge to you.
- First Name*
- Last Name*
- Street Address*
- Apt. #
- City*
- State*
AlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutDelawareDistrict of ColumbiaFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtahVermontVirginiaWashingtonWest VirginiaWisconsinWyomingArmed Forces AmericasArmed Forces EuropeArmed Forces Pacific
- Zip Code*
- Phone*
- Email*
- Which blood thinner did you or a loved one take at the time of the injury or injuries?*
- Pradaxa
- Xarelto
- Unknown
- Other
- Please check the injuries suffered:*
-
Death
-
Gastrointestinal Bleeding
-
Other Internal Bleeding
-
Cerebral Hemorrhaging
-
Unsure
-
None
-
- ¿Necesita un orador español?
- Yes
- No
- Please enter any additional details you would like the staff reviewing your submission to know.*
- I understand and agree that submitting this form does not create an attorney-client relationship and that the information I submit is not confidential or privileged and may be shared.*
-
Yes
-
-
if(typeof gf_global == ‘undefined’) var gf_global = {“gf_currency_config”:{“name”:”U.S. Dollar”,”symbol_left”:”$”,”symbol_right”:””,”symbol_padding”:””,”thousand_separator”:”,”,”decimal_separator”:”.”,”decimals”:2},”base_url”:”http:\/\/topclassactions.com\/wp-content\/plugins\/gravityforms”,”number_formats”:[],”spinnerUrl”:”http:\/\/topclassactions.com\/wp-content\/plugins\/gravityforms\/images\/spinner.gif”};jQuery(document).bind(‘gform_post_render’, function(event, formId, currentPage){if(formId == 24) {gformInitChosenFields(‘#input_24_5′,’No results matched’);if(!/(android)/i.test(navigator.userAgent)){jQuery(‘#input_24_7’).mask(‘(999) 999-9999’).bind(‘keypress’, function(e){if(e.which == 13){jQuery(this).blur();} } );}} } );jQuery(document).bind(‘gform_post_conditional_logic’, function(event, formId, fields, isInit){gformInitChosenFields(‘#input_24_5′,’No results matched’);} ); jQuery(document).ready(function(){jQuery(document).trigger(‘gform_post_render’, [24, 1]) } );
The post Pradaxa Antidote Release Date Scheduled For Late 2015 appeared first on Top Class Actions.
No comments:
Post a Comment